Renvela

Renvela

sevelamer

Manufacturer:

sanofi-aventis

Distributor:

DKSH
Concise Prescribing Info
Contents
Sevelamer carbonate
Indications/Uses
Control of hyperphosphataemia in adult patients receiving hemodialysis or peritoneal dialysis, or patients w/ chronic kidney disease not on dialysis w/ serum P ≥1.78 mmol/L.
Dosage/Direction for Use
1-2 tab tds, adjust 1 tab/meal in 2-wk intervals.
Administration
Should be taken with food.
Contraindications
Hypophosphatemia, bowel obstruction.
Special Precautions
Serious cases of dysphagia, bowel obstruction & perforation. Monitor serum bicarbonate & Cl levels.
Adverse Reactions
Nausea, vomiting, constipation; diarrhea, dyspepsia, abdominal pain, flatulence.
Drug Interactions
Ciprofloxacin, mycophenolate mofetil.
ATC Classification
V03AE02 - sevelamer ; Belongs to the class of drugs used in the treatment of hyperkalemia and hyperphosphatemia.
Presentation/Packing
Form
Renvela FC tab 800 mg
Packing/Price
180's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in